Cell Growth & Differentiation, Vol 7, Issue 6 711-715, Copyright © 1996 by American Association of Cancer Research

ARTICLES

BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells

JP Vaughn, PL Davis, MD Jarboe, G Huper, AC Evans, RW Wiseman, A Berchuck, JD Iglehart, PA Futreal and JR Marks
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

Insight into the function of the BRCA1 tumor suppressor gene may be gained by studying its regulation. In this study, the expression of BRCA1 was examined as a function of the cell cycle in normal and tumor-derived breast epithelial cells. Cells arrested in G(zero) or early in G1 contained low levels of BRCA1 mRNA. After release, populations of cells reached maximal levels of BRCA1 in late G1 and S phase. Induction of BRCA1 was shown to occur before the onset of DNA synthesis by synchronizing cells at the G1-S boundary. Levels of the BRCA1 protein were regulated in a similar manner. No difference was observed between primary cultures of normal mammary epithelial cells and immortalized tumor-derived cell lines. These results suggest that BRCA1 may function at the G1-S checkpoint.

This article has been cited by other articles:

				J. M. Saunus, J. D. French, S. L. Edwards, D. J. Beveridge, E. C. Hatchell, S. A. Wagner, S. R. Stein, A. Davidson, K. J. Simpson, G. D. Francis, et al. Posttranscriptional Regulation of the Breast Cancer Susceptibility Gene BRCA1 by the RNA Binding Protein HuR Cancer Res., November 15, 2008; 68(22): 9469 - 9478. [Abstract] [Full Text] [PDF]

				J. I. Weberpals, K. V. Clark-Knowles, and B. C. Vanderhyden Sporadic Epithelial Ovarian Cancer: Clinical Relevance of BRCA1 Inhibition in the DNA Damage and Repair Pathway J. Clin. Oncol., July 1, 2008; 26(19): 3259 - 3267. [Abstract] [Full Text] [PDF]

				G. Huper and J. R. Marks Isogenic Normal Basal and Luminal Mammary Epithelial Isolated by a Novel Method Show a Differential Response to Ionizing Radiation Cancer Res., April 1, 2007; 67(7): 2990 - 3001. [Abstract] [Full Text] [PDF]

				R. S. Muraoka-Cook, L. S. Caskey, M. A. Sandahl, D. M. Hunter, C. Husted, K. E. Strunk, C. I. Sartor, W. A. Rearick Jr., W. McCall, M. K. Sgagias, et al. Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1. Mol. Cell. Biol., September 1, 2006; 26(17): 6412 - 6424. [Abstract] [Full Text] [PDF]

				C.-X. Deng BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution Nucleic Acids Res., March 6, 2006; 34(5): 1416 - 1426. [Abstract] [Full Text] [PDF]

				F. Al-Mulla, M. Abdulrahman, G. Varadharaj, N. Akhter, and J. T. Anim BRCA1 Gene Expression in Breast Cancer: A Correlative Study between Real-time RT-PCR and Immunohistochemistry J. Histochem. Cytochem., May 1, 2005; 53(5): 621 - 629. [Abstract] [Full Text] [PDF]

				B. P. C. Chen, D. W. Chan, J. Kobayashi, S. Burma, A. Asaithamby, K. Morotomi-Yano, E. Botvinick, J. Qin, and D. J. Chen Cell Cycle Dependence of DNA-dependent Protein Kinase Phosphorylation in Response to DNA Double Strand Breaks J. Biol. Chem., April 15, 2005; 280(15): 14709 - 14715. [Abstract] [Full Text] [PDF]

				R.-H. Wang, H. Yu, and C.-X. Deng A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint PNAS, December 7, 2004; 101(49): 17108 - 17113. [Abstract] [Full Text] [PDF]

				S. S. Kim, L. Cao, C. Li, X. Xu, L. J. Huber, L. A. Chodosh, and C.-X. Deng Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1 Mol. Cell. Biol., November 1, 2004; 24(21): 9498 - 9507. [Abstract] [Full Text] [PDF]

				A. D. Choudhury, H. Xu, and R. Baer Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression J. Biol. Chem., August 6, 2004; 279(32): 33909 - 33918. [Abstract] [Full Text] [PDF]

				Z. Feng, L. Kachnic, J. Zhang, S. N. Powell, and F. Xia DNA Damage Induces p53-dependent BRCA1 Nuclear Export J. Biol. Chem., July 2, 2004; 279(27): 28574 - 28584. [Abstract] [Full Text] [PDF]

				T I Orban and E Olah Emerging roles of BRCA1 alternative splicing Mol. Pathol., August 1, 2003; 56(4): 191 - 197. [Abstract] [Full Text] [PDF]

				G. Baldassarre, S. Battista, B. Belletti, S. Thakur, F. Pentimalli, F. Trapasso, M. Fedele, G. Pierantoni, C. M. Croce, and A. Fusco Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma Mol. Cell. Biol., April 1, 2003; 23(7): 2225 - 2238. [Abstract] [Full Text] [PDF]

				T. Miralem and H. K. Avraham Extracellular Matrix Enhances Heregulin-Dependent BRCA1 Phosphorylation and Suppresses BRCA1 Expression through Its C Terminus Mol. Cell. Biol., January 15, 2003; 23(2): 579 - 593. [Abstract] [Full Text] [PDF]

				T. Hirota, T. Okano, K. Kokame, H. Shirotani-Ikejima, T. Miyata, and Y. Fukada Glucose Down-regulates Per1 and Per2 mRNA Levels and Induces Circadian Gene Expression in Cultured Rat-1 Fibroblasts J. Biol. Chem., November 8, 2002; 277(46): 44244 - 44251. [Abstract] [Full Text] [PDF]

				J. L. Hilton, J. P. Geisler, J. A. Rathe, M. A. Hattermann-Zogg, B. DeYoung, and R. E. Buller Inactivation of BRCA1 and BRCA2 in Ovarian Cancer J Natl Cancer Inst, September 18, 2002; 94(18): 1396 - 1406. [Abstract] [Full Text] [PDF]

				M. Fabbro, J. A. Rodriguez, R. Baer, and B. R. Henderson BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export J. Biol. Chem., June 7, 2002; 277(24): 21315 - 21324. [Abstract] [Full Text] [PDF]

				A. Menssen and H. Hermeking From the Cover: Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes PNAS, April 30, 2002; 99(9): 6274 - 6279. [Abstract] [Full Text] [PDF]

				L. J. Huber, T. W. Yang, C. J. Sarkisian, S. R. Master, C.-X. Deng, and L. A. Chodosh Impaired DNA Damage Response in Cells Expressing an Exon 11-Deleted Murine Brca1 Variant That Localizes to Nuclear Foci Mol. Cell. Biol., June 15, 2001; 21(12): 4005 - 4015. [Abstract] [Full Text]

				L. J. Havrilesky, C. P. McMahon, E. K. Lobenhofer, R. Whitaker, J. R. Marks, and A. Berchuck Relationship Between Expression of Coactivators and Corepressors of Hormone Receptors and Resistance of Ovarian Cancers to Growth Regulation by Steroid Hormones Reproductive Sciences, April 1, 2001; 8(2): 104 - 113. [Abstract] [PDF]

				R. E. Buller, T. A. Lallas, M. S. Shahin, A. K. Sood, M. Hatterman-Zogg, B. Anderson, J. I. Sorosky, and P. A. Kirby The p53 Mutational Spectrum Associated with BRCA1 Mutant Ovarian Cancer Clin. Cancer Res., April 1, 2001; 7(4): 831 - 838. [Abstract] [Full Text]

				J. A. Thompson, P-L. Chen, R. A. King, S. S. Rich, W. S. Oetting, C. Armstrong, A. R. Folsom, and T. A. Sellers BRCA1 Susceptibility Markers and Postmenopausal Breast Cancer: The Iowa Women's Health Study Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 507 - 511. [Abstract] [Full Text]

				A. Wang, R. Schneider-Broussard, A. P. Kumar, M. C. MacLeod, and D. G. Johnson Regulation of BRCA1 Expression by the Rb-E2F Pathway J. Biol. Chem., February 11, 2000; 275(6): 4532 - 4536. [Abstract] [Full Text] [PDF]

				E. K. Lobenhofer, G. Huper, J. D. Iglehart, and J. R. Marks Inhibition of Mitogen-activated Protein Kinase and Phosphatidylinositol 3-Kinase Activity in MCF-7 Cells Prevents Estrogen-induced Mitogenesis Cell Growth Differ., February 1, 2000; 11(2): 99 - 110. [Abstract] [Full Text]

				G. M. Pao, R. Janknecht, H. Ruffner, T. Hunter, and I. M. Verma CBP/p300 interact with and function as transcriptional coactivators of BRCA1 PNAS, February 1, 2000; 97(3): 1020 - 1025. [Abstract] [Full Text] [PDF]

				J.-S. LEE, K. COLLINS, A. BROWN, C.-H. LEE, and J.H. CHUNG The Function of BRCA1 in DNA Damage Response Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 547 - 552. [Abstract] [PDF]

				D. Cortez, Y. Wang, J. Qin, and S. J. Elledge Requirement of ATM-Dependent Phosphorylation of Brca1 in the DNA Damage Response to Double-Strand Breaks Science, November 5, 1999; 286(5442): 1162 - 1166. [Abstract] [Full Text]

				T.-C. Suen and P. E. Goss Transcription of BRCA1 Is Dependent on the Formation of a Specific Protein-DNA Complex on the Minimal BRCA1 Bi-directional Promoter J. Biol. Chem., October 29, 1999; 274(44): 31297 - 31304. [Abstract] [Full Text] [PDF]

				O. N. Aprelikova, B. S. Fang, E. G. Meissner, S. Cotter, M. Campbell, A. Kuthiala, M. Bessho, R. A. Jensen, and E. T. Liu BRCA1-associated growth arrest is RB-dependent PNAS, October 12, 1999; 96(21): 11866 - 11871. [Abstract] [Full Text] [PDF]

				H. Kaji, L. Canaff, D. Goltzman, and G. N. Hendy Cell Cycle Regulation of Menin Expression Cancer Res., October 1, 1999; 59(20): 5097 - 5101. [Abstract] [Full Text] [PDF]

				H. Ruffner, W. Jiang, A. G. Craig, T. Hunter, and I. M. Verma BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site Mol. Cell. Biol., July 1, 1999; 19(7): 4843 - 4854. [Abstract] [Full Text] [PDF]

				L.-C. Hsu and R. L. White BRCA1 is associated with the centrosome during mitosis PNAS, October 27, 1998; 95(22): 12983 - 12988. [Abstract] [Full Text] [PDF]

				L. De Petrocellis, D. Melck, A. Palmisano, T. Bisogno, C. Laezza, M. Bifulco, and V. Di Marzo The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation PNAS, July 7, 1998; 95(14): 8375 - 8380. [Abstract] [Full Text] [PDF]

				Y. Jin, X. L. Xu, M.-C. W. Yang, F. Wei, T.-C. Ayi, A. M. Bowcock, and R. Baer Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains PNAS, October 28, 1997; 94(22): 12075 - 12080. [Abstract] [Full Text] [PDF]

				H. Ruffner and I. M. Verma BRCA1 is a cell cycle-regulated nuclear phosphoprotein PNAS, July 8, 1997; 94(14): 7138 - 7143. [Abstract] [Full Text] [PDF]

				T Ludwig, D L Chapman, V E Papaioannou, and A Efstratiadis Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes & Dev., May 15, 1997; 11(10): 1226 - 1241. [Abstract] [PDF]

				J. E. Thomas, M. Smith, B. Rubinfeld, M. Gutowski, R. P. Beckmann, and P. Polakis Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1 J. Biol. Chem., November 8, 1996; 271(45): 28630 - 28635. [Abstract] [Full Text] [PDF]

				T M Smith, M K Lee, C I Szabo, N Jerome, M McEuen, M Taylor, L Hood, and M C King Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res., November 1, 1996; 6(11): 1029 - 1049. [Abstract] [PDF]

				C. J. Sarkisian, S. R. Master, L. J. Huber, S. I. Ha, and L. A. Chodosh Analysis of Murine Brca2 Reveals Conservation of Protein-Protein Interactions but Differences in Nuclear Localization Signals J. Biol. Chem., September 28, 2001; 276(40): 37640 - 37648. [Abstract] [Full Text] [PDF]

				X. Yu and R. Baer Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor J. Biol. Chem., June 9, 2000; 275(24): 18541 - 18549. [Abstract] [Full Text] [PDF]

				T. T. Paull, D. Cortez, B. Bowers, S. J. Elledge, and M. Gellert From the Cover: Direct DNA binding by Brca1 PNAS, May 22, 2001; 98(11): 6086 - 6091. [Abstract] [Full Text] [PDF]